Confido Health has raised $10 million in a Series A round to expand its AI-powered voice platform, bringing the company’s total funding to $13 million.
The round was led by Blume Ventures, with support from Schema Ventures, Vicus Ventures, Together Fund, DeVC, Medmountain Ventures, and strategic investors including Innovaccer, Memora Health, and existing customers.
The company is tackling one of healthcare’s biggest pain points which is patient phone calls. Despite digital options, 81% of patients in 2025 still use the phone to contact doctors, often facing long waits, confusing menus, or delayed responses. On the other side, understaffed front desks struggle to manage the volume, leading to frustration and burnout.
Confido’s platform removes the traditional phone tree. Its voice agents answer calls immediately, verify the caller, check insurance eligibility, and handle tasks such as referrals, refills, payments, updates, or appointment bookings. More complex issues are transferred to staff, with all interactions recorded directly into electronic health record (EHR) or practice management systems (PMS).
The need for such automation is increasing. The American Hospital Association has warned that hospitals are under severe financial strain while demand for round-the-clock access keeps growing. Many startups have entered this space in 2025, but Confido differentiates itself by offering a broader range of workflows beyond scheduling, giving providers higher efficiency and return on investment.
In less than a year, the company has scaled rapidly, serving more than one million patients today compared to just 150,000 in December 2024. Automation rates exceed 80%, with clients reporting reduced wait times, faster resolutions, and significant time savings for staff.
At Dallas Renal Group, results were immediate as 66% of patients confirmed appointments instantly on outbound calls, fewer than 6% required staff involvement, and inbound call wait times dropped to 15 seconds, saving nearly 50 staff hours in a single week. “Confido has helped make access faster, smoother, and far less stressful for everyone,” said Srinivas Danda, COO of Dallas Renal Group.
Confido’s Co-founder and CEO, Chetan Reddy, stressed the urgency of the moment. “Healthcare is at an inflection point. Labour shortages and rising patient demand mean practices can’t keep scaling front desks the way they used to. At the same time, building AI for healthcare isn’t like other industries – it requires deep empathy for both staff and patients. Our agents are designed to support people, not replace them, so patients get faster access and workers feel less stressed. That combination is what makes this moment so powerful.”
The company already operates across multiple specialities, including paediatrics, orthopaedics, nephrology, dermatology, gastroenterology, and pain medicine. Its roadmap goes beyond scheduling to include recalls, reactivation, payments, and care coordination, with speciality playbooks, audit trails, analytics, and first-call resolution metrics.
Investors are confident in Confido’s position. Sanjay Nath, partner at Blume Ventures, said: “Chetan, Vichar and the Confido team have gone incredibly deep into the trenches of the healthcare industry, having faced the pains of poor patient experience themselves – and have emerged with an offering that is transforming the way patient communication with providers is run.
“It is clear to us that healthcare especially in the US is ripe for AI-led transformation, given the widespread administrative staff shortages, and Confido Health is well positioned to 10X the patient experience. We are very excited to lead this investment round and see a clear path to Confido becoming the market leader in this space, driven by a patient-first product ethos and close partnership with the provider ecosystem.”
Shubham Gupta, founding general partner at Together Fund, added: “Chetan, Vichar, and the Confido team have gone deeper than anyone we’ve seen in tackling the patient access problem. Their fully generative, multi-agent platform is not just a tech innovation — it’s already proving its impact in real-world provider settings by handling the communication bottlenecks that EHRs and legacy vendors have consistently failed at.
“They are also building the most differentiated tech in this space focused on data & integrations not just voice. We’re excited to partner with them in building the market leader in AI-powered patient engagement.”
Confido Health believes that phones will remain healthcare’s most common entry point. In turning calls into efficient, human-like conversations, the company aims to become the standard infrastructure for patient communication across clinics and health systems of every size.
